Rinta Ibuki

Mitsubishi Group (Japan) JP

Publications

1,123

Citations

H-Index

i10-Index

0.5

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Establishment of new preparation method for solid dispersion formulation of tacrolimus

Kazunari Yamashita, Toshiomi Nakate, Kazuto Okimoto, Atsuo Ohike, Yuji Tokunaga +3 more

International Journal of Pharmaceutics 2003

343

Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats

Shigeki Tamura, Atsuo Ohike, Rinta Ibuki, Gordon L. Amidon, Shinji Yamashita

Journal of Pharmaceutical Sciences 2002

134

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga +3 more

Journal of Controlled Release 2006

Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose

Kazuto Okimoto, Masatoshi Miyake, Rinta Ibuki, Mituru Yasumura, Norio Ohnishi +1 more

International Journal of Pharmaceutics 1997

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga +4 more

Journal of Controlled Release 2005

Publications

28 total

Potential of Fairy Chemicals as Functional Cosmetic Ingredients: Effect of 2-Aza-8-Oxohypoxanthine on Skin Lightness.

H. Aoshima, S. Ito, R. Ibuki, H. Kawagishi - International Journal of Medicinal Mushrooms, 2022

Cited by 5 Semantic Scholar

Safety evaluation of 2-aza-8-oxohypoxanthine by in vitro skin sensitization and human tests OA

H. Aoshima, Takunori Matsumoto, R. Ibuki, H. Kawagishi - Fundamental Toxicological Sciences, 2021

Cited by 7 Semantic Scholar

The Potential of 2-aza-8-Oxohypoxanthine as a Cosmetic Ingredient OA

H. Aoshima, Masayuki Ito, R. Ibuki, H. Kawagishi - Cosmetics, 2021

Cited by 5 Semantic Scholar

Clinical Evaluation of Topical Lotion Containing 2-Aza-8-Oxohypoxanthine on Skin Barrier Function against Water Loss OA

H. Aoshima, R. Ibuki, Masayuki Ito, H. Kawagishi - Cosmetics, 2021

Cited by 5 Semantic Scholar

Safety evaluation of 2-aza-8-oxohypoxanthine based on in vitro and human patch tests OA

H. Aoshima, Sayuri Hyodo, R. Ibuki, Jing Wu, Jae-Hoon Choi - Unknown Venue, 2020

Cited by 9 Semantic Scholar

Synthesis of 14C labeled C60 with higher specific radioactivity

T. Tadai, K. Akiyama, H. Aoshima, R. Ibuki, S. Kubuki - Journal of Radioanalytical and Nuclear Chemistry, 2015

Cited by 0 Semantic Scholar

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga et al. - Journal of Controlled Release, 2006

Cited by 93 OpenAlex

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga et al. - Journal of Controlled Release, 2005

Cited by 76 OpenAlex

Improvement in the variation of inhalation properties of an FK888 dry powder inhaler using an E-haler, by adding coarse lactose in spherical soft agglomerates of fine drug particles, and its absorption in healthy volunteers

T. Nakate, H. Yoshida, A. Ohike, Y. Tokunaga, R. Ibuki - Unknown Venue, 2005

Cited by 1 Semantic Scholar

Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)

Kazuto Okimoto, Yuji Tokunaga, Rinta Ibuki, Tetsumi Irie, Kaneto Uekama et al. - International Journal of Pharmaceutics, 2004

Cited by 49 OpenAlex

Research Topics

Drug Solubulity and Delivery Systems (8) Advanced Drug Delivery Systems (6) Asthma and respiratory diseases (4) Drug Transport and Resistance Mechanisms (4) Skin Protection and Aging (4)

Frequent Co-Authors

Atsuo Ohike

8 joint publications

Yuji Tokunaga

8 joint publications

Kazuto Okimoto

7 joint publications

Satoshi Ueda

4 joint publications

Toshiomi Nakate

3 joint publications

Kazutaka Higaki

3 joint publications

Affiliations

Mitsubishi Group (Japan)

JP 2025 - 2025

Astellas Pharma (Japan)

JP 2006 - 2006

Mochida Pharmaceutical (Japan)

JP 1999 - 1998

Fujisawa City Hospital

JP 2005 - 1994

Astellas Pharma (China)

CN 2003 - 2003

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Rinta Ibuki

Publication & Citation Trends

Most Cited Works

Publications

Potential of Fairy Chemicals as Functional Cosmetic Ingredients: Effect of 2-Aza-8-Oxohypoxanthine on Skin Lightness.

Safety evaluation of 2-aza-8-oxohypoxanthine by in vitro skin sensitization and human tests OA

The Potential of 2-aza-8-Oxohypoxanthine as a Cosmetic Ingredient OA

Clinical Evaluation of Topical Lotion Containing 2-Aza-8-Oxohypoxanthine on Skin Barrier Function against Water Loss OA

Safety evaluation of 2-aza-8-oxohypoxanthine based on in vitro and human patch tests OA

Synthesis of 14C labeled C60 with higher specific radioactivity

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine

Improvement in the variation of inhalation properties of an FK888 dry powder inhaler using an E-haler, by adding coarse lactose in spherical soft agglomerates of fine drug particles, and its absorption in healthy volunteers

Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back